SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-088551
Filing Date
2021-07-02
Accepted
2021-07-02 07:01:00
Documents
5
Period of Report
2021-08-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2120989-2_def14a.htm DEF 14A 466423
2 GRAPHIC lg_neubase-bwlr.jpg GRAPHIC 23165
3 GRAPHIC sg_dietrichstephannew-bw.jpg GRAPHIC 5775
4 GRAPHIC tm2120989d2-proxy_neupg1bw.jpg GRAPHIC 517189
5 GRAPHIC tm2120989d2-proxy_neupg2bw.jpg GRAPHIC 386756
  Complete submission text file 0001104659-21-088551.txt   1751706
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-35963 | Film No.: 211067960
SIC: 2834 Pharmaceutical Preparations